uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Capital Expenditures (2016 - 2026)

uniQure (QURE) posted Capital Expenditures of $472000.0 for Q2 2026, up 237.14% on a QoQ basis from $140000.0 in Q1 2026, and up 81.54% year-over-year from $260000.0 in Q2 2025.

Analysis

uniQure (QURE) Capital Expenditures (2016 - 2026) Analysis & Trends

uniQure has reported Capital Expenditures for 11 years, with the latest figure at $472000.0 in Q2 2026.

  • On a quarterly basis, Capital Expenditures rose 81.54% year-over-year to $472000.0 in Q2 2026; TTM through Jun 2026 was $665000.0, a 17.49% decrease from a year earlier, with the FY2025 full-year figure at $439000.0, down 86.97% from the prior year.
  • Capital Expenditures was $472000.0 for Q2 2026 at uniQure, up from $140000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $5.1 million in Q4 2022, with the low at -$66000.0 in Q3 2025.
  • Average Capital Expenditures over 5 years is $1.6 million, with a median of $839000.0 recorded in 2023.
  • The largest YoY upside for Capital Expenditures was 197.5% in 2025 against a maximum downside of 117.37% in 2025.
  • Over 5 years, Capital Expenditures stood at $5.1 million in 2022, then plunged by 59.77% to $2.0 million in 2023, then sank by 98.04% to $40000.0 in 2024, then jumped by 197.5% to $119000.0 in 2025, then soared by 296.64% to $472000.0 in 2026.
  • The last three Capital Expenditures figures came in at $472000.0 (Q2 2026), $140000.0 (Q1 2026), and $119000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 1.32 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 322.00 Mn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -763.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 140.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 112.20 Mn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn 472,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 472,000.00
Mar 31, 2026 140,000.00
Dec 31, 2025 119,000.00
Sep 30, 2025 -66,000.00
Jun 30, 2025 260,000.00
Mar 31, 2025 126,000.00
Dec 31, 2024 40,000.00
Sep 30, 2024 380,000.00
Jun 30, 2024 604,000.00
Mar 31, 2024 2.34 Mn
Dec 31, 2023 2.04 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.07 Mn
Mar 31, 2023 2.34 Mn
Dec 31, 2022 5.07 Mn
Sep 30, 2022 3.99 Mn
Jun 30, 2022 4.58 Mn
Mar 31, 2022 4.06 Mn
Dec 31, 2021 3.55 Mn
Sep 30, 2021 7.69 Mn
API Access

uniQure Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=QURE&period=max&api_key=YOUR_API_KEY